Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

被引:0
|
作者
Jeroen J. A. van Kampen
David A. M. C. van de Vijver
Pieter L. A. Fraaij
Bart L. Haagmans
Mart M. Lamers
Nisreen Okba
Johannes P. C. van den Akker
Henrik Endeman
Diederik A. M. P. J. Gommers
Jan J. Cornelissen
Rogier A. S. Hoek
Menno M. van der Eerden
Dennis A. Hesselink
Herold J. Metselaar
Annelies Verbon
Jurriaan E. M. de Steenwinkel
Georgina I. Aron
Eric C. M. van Gorp
Sander van Boheemen
Jolanda C. Voermans
Charles A. B. Boucher
Richard Molenkamp
Marion P. G. Koopmans
Corine Geurtsvankessel
Annemiek A. van der Eijk
机构
[1] Erasmus MC,Department of Viroscience
[2] Subdivision Infectious Diseases and Immunology,Department of Pediatrics
[3] Erasmus MC - Sophia,Department of Intensive Care
[4] Erasmus MC,Department of Hematology
[5] Erasmus MC,Department of Pulmonary Medicine
[6] Erasmus MC,Department of Internal Medicine, Division of Nephrology and Transplantation
[7] Erasmus MC Transplant Institute,Department of Gastroenterology and Hepatology
[8] Erasmus MC,Department of Medical Microbiology and Infectious Diseases
[9] Erasmus MC,undefined
[10] Erasmus MC,undefined
来源
Nature Communications | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Key questions in COVID-19 are the duration and determinants of infectious virus shedding. Here, we report that infectious virus shedding is detected by virus cultures in 23 of the 129 patients (17.8%) hospitalized with COVID-19. The median duration of shedding infectious virus is 8 days post onset of symptoms (IQR 5–11) and drops below 5% after 15.2 days post onset of symptoms (95% confidence interval (CI) 13.4–17.2). Multivariate analyses identify viral loads above 7 log10 RNA copies/mL (odds ratio [OR] of 14.7 (CI 3.57-58.1; p < 0.001) as independently associated with isolation of infectious SARS-CoV-2 from the respiratory tract. A serum neutralizing antibody titre of at least 1:20 (OR of 0.01 (CI 0.003-0.08; p < 0.001) is independently associated with non-infectious SARS-CoV-2. We conclude that quantitative viral RNA load assays and serological assays could be used in test-based strategies to discontinue or de-escalate infection prevention and control precautions.
引用
收藏
相关论文
共 50 条
  • [31] The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome
    Salaffi, F.
    Giorgi, V
    Sirotti, S.
    Bongiovanni, S.
    Farah, S.
    Bazzichi, L.
    Marotto, D.
    Atzeni, F.
    Rizzi, M.
    Batticciotto, A.
    Lombardi, G.
    Galli, M.
    Sarzi-Puttini, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : S72 - S77
  • [32] A Review of COVID-19 (Coronavirus Disease-2019) Diagnosis, Treatments and Prevention
    Hafeez, Abdul
    Ahmad, Shmmon
    Siddqui, Sameera Ali
    Ahmad, Mumtaz
    Mishra, Shruti
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2020, 4 (02): : 116 - 125
  • [33] Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review
    Samaranayake, Lakshman P.
    Fakhruddin, Kausar S.
    Ngo, Hien C.
    Bandara, H. M. N. M.
    Leung, Y. Y.
    INTERNATIONAL DENTAL JOURNAL, 2022, 72 (05) : 607 - 620
  • [34] Clinical Outcomes of Patients Hospitalized with Coronavirus Disease 2019 (COVID-19) in Boston
    El-Jawahri, Areej
    Bohossian, Hacho B.
    Paasche-Orlow, Michael K.
    Lakin, Joshua R.
    Johnson, P. Connor
    Cooper, Zara
    Jagielo, Annemarie D.
    Brannen, Elise N.
    Reynolds, Matthew J.
    Coogan, Kathleen
    Vaughn, Dagny
    Volandes, Angelo
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (05) : 1285 - 1291
  • [35] Clinical Outcomes of Patients Hospitalized with Coronavirus Disease 2019 (COVID-19) in Boston
    Areej El-Jawahri
    Hacho B. Bohossian
    Michael K. Paasche-Orlow
    Joshua R. Lakin
    P. Connor Johnson
    Zara Cooper
    Annemarie D. Jagielo
    Elise N. Brannen
    Matthew J. Reynolds
    Kathleen Coogan
    Dagny Vaughn
    Angelo Volandes
    Journal of General Internal Medicine, 2021, 36 : 1285 - 1291
  • [36] Caring for Miners During the Coronavirus Disease-2019 (COVID-19) Pandemic
    Sood, Akshay
    Pollard, Charles
    Suer, Kyla Le
    Vlahovich, Kevin
    Walker, Jolene
    JOURNAL OF RURAL HEALTH, 2021, 37 (01): : 165 - 168
  • [37] Serum Homocysteine Level and Severity of Coronavirus Disease-2019 (COVID-19)
    Siregar, Jelita
    Darmadi, Darmadi
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2023, 61 (02) : 106 - 111
  • [38] Administration of the Coronavirus Disease 2019 (COVID-19) Vaccine to Hospitalized Postpartum Patients
    Perez, Marta J.
    Paul, Rachel
    Hirshberg, Jonathan S.
    Aibangbee, Erica
    Ford, Tiana
    Cooke, Emily
    Carter, Ebony B.
    Odibo, Anthony O.
    Raghuraman, Nandini
    Kelly, Jeannie C.
    OBSTETRICS AND GYNECOLOGY, 2021, 138 (06): : 885 - 887
  • [39] Attributes of dysgeusia and anosmia of coronavirus disease 2019 (COVID-19) in hospitalized patients
    Samaranayake, Lakshman Perera
    Fakhruddin, Kausar Sadia
    Mohammad, Osman Elfadil
    Panduwawala, Chamila
    Bandara, Nihal
    Ngo, Hien Chi
    ORAL DISEASES, 2022, 28 : 891 - 898
  • [40] Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
    Schoergenhofer, Christian
    Jilma, Bernd
    Stimpfl, Thomas
    Karolyi, Mario
    Zoufaly, Alexander
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : 670 - +